#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dermatitis atopic Breast cancer metastatic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Giant cell tumour of tendon sheath Hypochondroplasia Ewing's sarcoma metastatic Angiosarcoma Heritable pulmonary arterial hypertension Lymphoma Von Hippel-Lindau disease Progressive familial intrahepatic cholestasis Acute lymphocytic leukaemia Plasma cell myeloma Oesophageal atresia Adult T-cell lymphoma/leukaemia refractory Alternating hemiplegia of childhood Mixed-type liposarcoma Chronic lymphocytic leukaemia More trials…

    Learn about Rare Diseases

    Progressive multifocal leukoencephalopathy – Treatment Mucopolysaccharidosis – Life with Disease Metachromatic leukodystrophy Haemophilia A with anti factor VIII – Basic Information Glomerulonephritis rapidly progressive – Treatment Splenic marginal zone lymphoma Hereditary motor and sensory neuropathy – Treatment Primary mediastinal large B-cell lymphoma – Treatment Angiosarcoma recurrent – Diagnostics Brain stem glioma – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Anhydrous Docetaxel Tumour Detection Sotagliflozin Brodalumab Pramlintide Acetate Nizaracianine Triflutate Mavorixafor Bcmacp03 Vibegron Potassium Chloride Disodium Folinate Octreotide Resiniferatoxin Fluvastatin Sodium Apixaban Voxelotor HYPOCHLOROUS ACID Iti-1284 Ht-29-B Ziprasidone More therapies…

    Learn about Your Condition

    Back pain Hyperplasia adrenal Cardiac failure acute Infection Complex regional pain syndrome Shprintzen-Goldberg syndrome Diabetic ketoacidosis Spinal cord injury cervical Genitourinary tract neoplasm Pterygium Premature baby Breast conserving surgery Infertility Body mass index increased Diabetic retinal oedema More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • Study of CC-97540 CD19-targeted CAR T cells in patients with systemic lupus erythematosus who did not respond to previous immunosuppressive treatment

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Systemic lupus erythematosus
    • Lupus nephritis
    Investigated Drugs:
    • Fludarabine
    • CC-97540
    • Fludarabine Phosphate
    Austria Belgium Denmark France Germany Italy +3

  • Evaluation of opioid use with nociceptive monitoring in intensive care patients receiving deep sedation with isoflurane, propofol, and midazolam

    Not yet recruiting

    3 1 1 1
    Investigated Drugs:
    • Dobutamine Hydrochloride
    • Isoflurane
    • Propofol
    Spain

  • Study of Anakinra compared to placebo for treating acute myocarditis in children admitted to intensive care units

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Myocarditis
    Investigated Drugs:
    • Anakinra
    • Sodium Chloride
    France

  • Study of early dapagliflozin treatment to reduce heart damage in patients with acute heart attack and reduced heart pumping function

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Acute myocardial infarction
    Investigated Drugs:
    • Dapagliflozin
    Italy

  • Study of safinamide compared to placebo for pain relief in patients with Parkinson’s disease who experience motor fluctuations

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Parkinson’s disease
    Investigated Drugs:
    • Safinamide
    Italy

  • Study of early versus late risankizumab treatment to evaluate immune cell response in patients with moderate to severe psoriasis

    Not yet recruiting

    3 1 1
    Investigated Drugs:
    • Risankizumab
    Spain
Previous Page
1 … 772 773 774 775 776 … 1,657
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!